Search Results - "ZANGERLE, Robert"

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy by Rodger, Alison J, Cambiano, Valentina, Bruun, Tina, Vernazza, Pietro, Collins, Simon, van Lunzen, Jan, Corbelli, Giulio Maria, Estrada, Vicente, Geretti, Anna Maria, Beloukas, Apostolos, Asboe, David, Viciana, Pompeyo, Gutiérrez, Félix, Clotet, Bonaventura, Pradier, Christian, Gerstoft, Jan, Weber, Rainer, Westling, Katarina, Wandeler, Gilles, Prins, Jan M, Rieger, Armin, Stoeckle, Marcel, Kümmerle, Tim, Bini, Teresa, Ammassari, Adriana, Gilson, Richard, Krznaric, Ivanka, Ristola, Matti, Zangerle, Robert, Handberg, Pia, Antela, Antonio, Allan, Sris, Phillips, Andrew N, Lundgren, Jens

“…IMPORTANCE: A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral therapy (ART) as a prevention strategy is the absolute risk of…”
Get full text

Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies by Trickey, Adam, May, Margaret T, Vehreschild, Jorg-Janne, Obel, Niels, Gill, M John, Crane, Heidi M, Boesecke, Christoph, Patterson, Sophie, Grabar, Sophie, Cazanave, Charles, Cavassini, Matthias, Shepherd, Leah, Monforte, Antonella d'Arminio, van Sighem, Ard, Saag, Mike, Lampe, Fiona, Hernando, Vicky, Montero, Marta, Zangerle, Robert, Justice, Amy C, Sterling, Timothy, Ingle, Suzanne M, Sterne, Jonathan A C

“…Summary Background Health care for people living with HIV has improved substantially in the past two decades. Robust estimates of how these improvements have…”
Get full text

Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy by Trickey, Adam, May, Margaret T, Vehreschild, Janne, Obel, Niels, Gill, Michael John, Crane, Heidi, Boesecke, Christoph, Samji, Hasina, Grabar, Sophie, Cazanave, Charles, Cavassini, Matthias, Shepherd, Leah, d'Arminio Monforte, Antonella, Smit, Colette, Saag, Michael, Lampe, Fiona, Hernando, Vicky, Montero, Marta, Zangerle, Robert, Justice, Amy C, Sterling, Timothy, Miro, Jose, Ingle, Suzanne, Sterne, Jonathan A C

“…To estimate mortality rates and prognostic factors in HIV-positive patients who started combination antiretroviral therapy between 1996-1999 and survived for…”
Get full text

HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors by Paraskevis, Dimitrios, Beloukas, Apostolos, Stasinos, Kostantinos, Pantazis, Nikos, de Mendoza, Carmen, Bannert, Norbert, Meyer, Laurence, Zangerle, Robert, Gill, John, Prins, Maria, d'Arminio Montforte, Antonella, Kran, Anne-Marte Bakken, Porter, Kholoud, Touloumi, Giota

“…Knowledge of HIV-1 molecular transmission clusters (MTCs) is important, especially in large-scale datasets, for designing prevention programmes and public…”
Get full text

Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study) by Sullivan, Ann K, Raben, Dorthe, Reekie, Joanne, Rayment, Michael, Mocroft, Amanda, Esser, Stefan, Leon, Agathe, Begovac, Josip, Brinkman, Kees, Zangerle, Robert, Grzeszczuk, Anna, Vassilenko, Anna, Hadziosmanovic, Vesna, Krasnov, Maksym, Sönnerborg, Anders, Clumeck, Nathan, Gatell, José, Gazzard, Brian, Monforte, Antonella d'Arminio, Rockstroh, Jürgen, Lundgren, Jens D

“…Improved methods for targeting HIV testing among patients most likely to be infected are required; HIDES I aimed to define the methodology of a European wide…”
Get full text

Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study by Leierer, Gisela, Grabmeier-Pfistershammer, Katharina, Steuer, Andrea, Geit, Maria, Sarcletti, Mario, Haas, Bernhard, Kanatschnig, Manfred, Rappold, Michaela, Zangerle, Robert, Ledergerber, Bruno, Taylor, Ninon

“…In human immunodeficiency virus treatment adequate virological suppression is warranted, nevertheless for some patients it remains a challenge. We investigated…”
Get full text

Risk of tuberculosis after initiation of antiretroviral therapy among persons with HIV in Europe by Johansen, Isik S., Roen, Ashley, Kraef, Christian, Martín-Iguacel, Raquel, Nemeth, Johannes, Fenner, Lukas, Zangerle, Robert, Llibre, Josep M., Miller, Robert F., Suarez, Isabelle, de Wit, Stephane, Wit, Ferdinand, Mussini, Christina, Saracino, Annalisa, Canetti, Diana, Volny-Anne, Alain, Jaschinski, Nadine, Neesgaard, Bastian, Ryom, Lene, Peters, Lars, Garges, Harmony P., Rooney, James F., Podlekareva, Daria, Mocroft, Amanda, Kirk, Ole

“…•The tuberculosis (TB) risk after antiretroviral treatment (ART) initiation in Europe is studied.•TB peaked within 3 months post ART (14.41/1000 PY).•TB was…”
Get full text

Increased blood phenylalanine to tyrosine ratio in HIV-1 infection and correction following effective antiretroviral therapy by Zangerle, Robert, Kurz, Katharina, Neurauter, Gabriele, Kitchen, Maria, Sarcletti, Mario, Fuchs, Dietmar

“…Abstract Objective Higher blood levels of the essential amino acid phenylalanine (phe) have been documented in patients with HIV-1 infection. They may relate…”
Get full text

Anal Ureaplasma spp. positivity among HIV positive men who have sex with men may be associated with high-risk-type HPV infections by Borena, Wegene, Kruis, Simon, Kitchen, Maria, Taylor, Ninon, Gisinger, Martin, Oberkofler, Hannes, Stoiber, Heribert, Zangerle, Robert, von Laer, Dorothee, Sarcletti, Mario

“…•One-in-five HIV-positive men having sex with men harboured anal Ureaplasma spp.•Ureaplasma Urealyticum was more commoly detected that Ureaplasma parvum.•Men…”
Get full text

Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection by Lodi, Sara, Fisher, Martin, Phillips, Andrew, De Luca, Andrea, Ghosn, Jade, Malyuta, Ruslan, Zangerle, Robert, Moreno, Santiago, Vanhems, Philippe, Boufassa, Faroudy, Guiguet, Marguerite, Porter, Kholoud

“…The risk/benefit of initiating ART in primary HIV infection (PHI) is unclear. The benefits are more likely to outweigh the risks in patients with severe PHI…”
Get full text

Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration by Touloumi, Giota, Pantazis, Nikos, Chaix, Marie-Laure, Bucher, Heiner C, Zangerle, Robert, Kran, Anne-Marte Bakken, Thiebaut, Rodolphe, Masquelier, Bernard, Kucherer, Claudia, Monforte, Antonella d'Arminio, Meyer, Laurence, Porter, Kholoud

“…We aimed to compare rates of virologic response and CD4 changes after combination antiretroviral (cART) initiation in individuals infected with B and specific…”
Get full text

Increased Cardiovascular Risk in Patients With Human Immunodeficiency Virus Infection Under Highly Active Antiretroviral Therapy by Zangerle, Robert, MD, Fuchs, Dietmar, PhD

Get full text

Low Proportion of Recent Human Immunodeficiency Virus (HIV) Infections among Newly Diagnosed Cases of HIV Infection as Shown by the Presence of HIV-Specific Antibodies of Low Avidity by Puchhammer-Stöckl, Elisabeth, Schmied, Brigitte, Rieger, Armin, Sarcletti, Mario, Geit, Maria, Zangerle, Robert, Hofmann, Hanns

“…The time between human immunodeficiency virus (HIV) infection and diagnosis is mostly unknown. Two hundred five newly diagnosed patients were investigated for…”
Get full text

Mycobacterium chelonae skin infection in kidney-pancreas recipient by Stelzmueller, Ingrid, Dunst, Karin M, Wiesmayr, Silke, Zangerie, Robert, Hengster, Paul, Bonatti, Hugo

Get full text

High seroprotection rates and geometric mean titre increases after repeated annual influenza vaccinations in a cohort of HIV-infected adults in Austria by Kitchen, Maria, Leierer, Gisela, Kistner, Otfried, Wodal, Walter, Gisinger, Martin, Zangerle, Robert, Sarcletti, Mario

“…Vaccination against seasonal influenza is recommended for all HIV-infected persons. Few data have been reported on the effect of repeated annual vaccination in…”
Get full text

Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies by Trickey, Adam, Sabin, Caroline A, Burkholder, Greer, Crane, Heidi, d'Arminio Monforte, Antonella, Egger, Matthias, Gill, M John, Grabar, Sophie, Guest, Jodie L, Jarrin, Inma, Lampe, Fiona C, Obel, Niels, Reyes, Juliana M, Stephan, Christoph, Sterling, Timothy R, Teira, Ramon, Touloumi, Giota, Wasmuth, Jan-Christian, Wit, Ferdinand, Wittkop, Linda, Zangerle, Robert, Silverberg, Michael J, Justice, Amy, Sterne, Jonathan A C

“…The life expectancy of people with HIV taking antiretroviral therapy (ART) has increased substantially over the past 25 years. Most previous studies of life…”
Get full text

Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals by Tate, Janet P, Sterne, Jonathan A.C, Justice, Amy C

“…OBJECTIVE:Despite viral suppression and immune response on antiretroviral therapy, people with HIV infection experience excess mortality compared with…”
Get full text

Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE) by Mocroft, Amanda, Lundgren, Jens D, Sabin, Miriam Lewis, Monforte, Antonella d'Arminio, Brockmeyer, Norbert, Casabona, Jordi, Castagna, Antonella, Costagliola, Dominique, Dabis, Francois, De Wit, Stéphane, Fätkenheuer, Gerd, Furrer, Hansjakob, Johnson, Anne M, Lazanas, Marios K, Leport, Catherine, Moreno, Santiago, Obel, Niels, Post, Frank A, Reekie, Joanne, Reiss, Peter, Sabin, Caroline, Skaletz-Rorowski, Adriane, Suarez-Lozano, Ignacio, Torti, Carlo, Warszawski, Josiane, Zangerle, Robert, Fabre-Colin, Céline, Kjaer, Jesper, Chene, Genevieve, Grarup, Jesper, Kirk, Ole

“…Few studies have monitored late presentation (LP) of HIV infection over the European continent, including Eastern Europe. Study objectives were to explore the…”
Get full text

High prevalence of high risk human papillomavirus-capsid antibodies in human immunodeficiency virus-seropositive men: a serological study by Höpfl, Reinhard, Petter, Anton, Thaler, Petra, Sarcletti, Mario, Widschwendter, Andreas, Zangerle, Robert

“…Serological study of human papillomavirus (HPV)-antibodies in order to estimate the HPV-prevalence as risk factor for the development of HPV-associated…”
Get full text

Feasibility and Effectiveness of Indicator ConditionGuided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study) by Sullivan, AK, Raben, D, Reekie, J, Rayment, M, Mocroft, A, Esser, S, Leon, A, Begovac, J, Brinkman, K, Zangerle, R

Get full text